Progyny Inc (PGNY)
16.80
+0.08
(+0.48%)
USD |
NASDAQ |
Sep 27, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Progyny SG&A Expense (TTM): 179.01M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 179.01M |
March 31, 2024 | 176.87M |
December 31, 2023 | 176.62M |
September 30, 2023 | 174.71M |
June 30, 2023 | 165.01M |
March 31, 2023 | 154.61M |
December 31, 2022 | 143.98M |
September 30, 2022 | 128.10M |
June 30, 2022 | 112.79M |
March 31, 2022 | 95.70M |
December 31, 2021 | 79.80M |
Date | Value |
---|---|
September 30, 2021 | 74.00M |
June 30, 2021 | 70.58M |
March 31, 2021 | 65.64M |
December 31, 2020 | 61.71M |
September 30, 2020 | 52.83M |
June 30, 2020 | 46.07M |
March 31, 2020 | 42.14M |
December 31, 2019 | 35.83M |
September 30, 2019 | 31.32M |
June 30, 2019 | 27.70M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
31.32M
Minimum
Sep 2019
179.01M
Maximum
Jun 2024
103.37M
Average
87.75M
Median
SG&A Expense (TTM) Benchmarks
Delcath Systems Inc | 28.74M |
Star Equity Holdings Inc | 16.08M |
Exact Sciences Corp | 1.624B |
Illumina Inc | 1.374B |
CytoSorbents Corp | 37.41M |